Akouos Inc AKUS:NASDAQ

Last Price$7.81NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/03/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$7.00 (1)
Ask (Size)$7.83 (12)
Day Low / HighN/A - N/A
Volume284.4 K
 

Read more news Recent News

Akouos Files for Up to $300 Million Mixed-Securities Shelf
7:08AM ET 8/16/2021 MT Newswires

Akouos (AKUS) late Friday registered with the US Securities and Exchange Commission to sell from time to time up to $300 million in various securities. ...

Akouos' Gene Therapy for Hearing Loss Gets Orphan Drug Designation in Europe
9:38AM ET 8/11/2021 MT Newswires

Akouos (AKUS) on Wednesday said the European Commission has adopted the positive opinion of the European Medicines Agency's Committee for Orphan Medicinal...

Akouos Q1 Loss Shrinks; Shares Gain Pre-Bell
9:09AM ET 5/13/2021 MT Newswires

Akouos (AKUS) on Thursday reported a Q1 net loss of $0.47 per share, compared with a $14.74 loss per share last year. Analysts polled by Capital IQ had...

Akouos Appoints Development Chief
4:27AM ET 5/10/2021 MT Newswires

Akouos (AKUS), a precision genetic medicine company, said Friday that Kathy Reape has been named chief development officer. Reape most recently served as...

View all Commentary and Analysis

Decibel Therapeutics: Gene Therapies For Hearing Loss
2:56PM ET 7/06/2021 Seeking Alpha

Akouos (AKUS) Investor Presentation - Slideshow
3:47PM ET 5/14/2021 Seeking Alpha

U.S. IPO Weekly Recap And Week Ahead
1:44PM ET 12/20/2020 Seeking Alpha

Wall Street Breakfast: The Week Ahead
7:10AM ET 12/20/2020 Seeking Alpha

Company Profile

Business Description
Number of EmployeesN/A
Recent SEC Filing11/12/20218-K

Company Highlights

Price Open$8.80
Previous Close$8.84
52 Week Range$7.48 - 23.49
Market Capitalization$269.4 M
Shares Outstanding34.5 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement04/04/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.16
Beta vs. S&P 500N/A
RevenueN/A
Net Profit MarginN/A
Return on Equity-26.06%

Analyst Ratings as of 10/10/2021

Buy
3
Overweight
0
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset